Leonardo Roever: Non-LDL Biomarkers and The Potential Future Applications for 2ry Stroke Prevention
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Sean Michael Kelly et al, published in Current Atherosclerosis Reports, adding:
”Rethinking Lipid Burden and the Role of Non-LDL Biomarkers in Stroke Risk Stratification
This article reviews the existing literature on non-LDL biomarkers in atherosclerotic cardiovascular disease (ASCVD), atherogenesis, and ischemic stroke risk, including a discussion on potential future applications for secondary stroke prevention.”
Title: Rethinking Lipid Burden and the Role of Non-LDL Biomarkers in Stroke Risk Stratification
Authors: Sean Michael Kelly, Julia Schneider, Michela Rosso, Koto Ishida, Sara Rostanski, Gregory Katz
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2